首页> 外文期刊>Annals of clinical biochemistry. >Statistical validation of reagent lot change in the clinical chemistry laboratory can confer insights on good clinical laboratory practice
【24h】

Statistical validation of reagent lot change in the clinical chemistry laboratory can confer insights on good clinical laboratory practice

机译:临床化学实验室中试剂批号变化的统计验证可以为良好的临床实验室实践提供见解

获取原文
获取原文并翻译 | 示例
       

摘要

Verification of new lot reagent’s suitability is necessary to ensure that results for patients’ samples are consistent before and after reagent lot changes. A typical procedure is to measure results of some patients’ samples along with quality control (QC) materials. In this study, the results of patients’ samples and QC materials in reagent lot changes were analysed. In addition, the opinion regarding QC target range adjustment along with reagent lot changes was proposed. Patients’ sample and QC material results of 360 reagent lot change events involving 61 analytes and eight instrument platforms were analysed. The between-lot differences for the patients’ samples (ΔP) and the QC materials (ΔQC) were tested by Mann–Whitney U tests. The size of the between-lot differences in the QC data was calculated as multiples of standard deviation (SD). The ΔP and ΔQC values only differed significantly in 7.8% of the reagent lot change events. This frequency was not affected by the assay principle or the QC material source. One SD was proposed for the cutoff for maintaining pre-existing target range after reagent lot change. While non-commutable QC material results were infrequent in the present study, our data confirmed that QC materials have limited usefulness when assessing new reagent lots. Also a 1 SD standard for establishing a new QC target range after reagent lot change event was proposed.
机译:必须对新批试剂的适用性进行验证,以确保在更换试剂批前后患者样本的结果一致。典型的程序是测量某些患者样品的结果以及质量控制(QC)材料。在这项研究中,分析了患者样品和质控物质在试剂批号更改中的结果。此外,还提出了有关质量控制目标范围调整以及试剂批号更改的意见。分析了360种试剂批次变更事件的患者样本和QC材料结果,涉及61种分析物和8种仪器平台。通过Mann-Whitney U检验对患者样品(ΔP)和质控材料(ΔQC)的批间差异进行了检验。 QC数据中批间差异的大小计算为标准偏差(SD)的倍数。在7.8%的试剂批次更改事件中,ΔP和ΔQC值仅存在显着差异。该频率不受测定原理或质控物质来源的影响。提出了一个标准差作为截止值,以在更换试剂批次后维持预先存在的目标范围。虽然在本研究中很少使用不可交换的QC材料结果,但我们的数据证实,在评估新试剂批次时,QC材料的用途有限。还提出了一种1 SD标准,用于在试剂批号更改事件之后建立新的QC目标范围。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号